Non-coding RNAs and their bioengineering applications for neurological diseases

Engineering of cellular biomolecules is an emerging landscape presenting creative therapeutic opportunities. Recently, several strategies such as biomimetic materials, drug-releasing scaffolds, stem cells, and dynamic culture systems have been developed to improve specific biological functions, howe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tuhin Das, Tushar Kanti Das, Anne Khodarkovskaya, Sabyasachi Dash
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/86f98868c6e049ffa0772884afa9dac1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:86f98868c6e049ffa0772884afa9dac1
record_format dspace
spelling oai:doaj.org-article:86f98868c6e049ffa0772884afa9dac12021-11-11T14:23:43ZNon-coding RNAs and their bioengineering applications for neurological diseases2165-59792165-598710.1080/21655979.2021.2003667https://doaj.org/article/86f98868c6e049ffa0772884afa9dac12021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.2003667https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Engineering of cellular biomolecules is an emerging landscape presenting creative therapeutic opportunities. Recently, several strategies such as biomimetic materials, drug-releasing scaffolds, stem cells, and dynamic culture systems have been developed to improve specific biological functions, however, have been confounded with fundamental and technical roadblocks. Rapidly emerging investigations on the bioengineering prospects of mammalian ribonucleic acid (RNA) is expected to result in significant biomedical advances. More specifically, the current trend focuses on devising non-coding (nc) RNAs as therapeutic candidates for complex neurological diseases. Given the pleiotropic and regulatory role, ncRNAs such as microRNAs and long non-coding RNAs are deemed as attractive therapeutic candidates. Currently, the list of non-coding RNAs in mammals is evolving, which presents the plethora of hidden possibilities including their current scope in biomedicine. Herein, we critically review on the emerging repertoire of ncRNAs in neurological diseases such as Alzheimer’s disease, Parkinson’s disease, neuroinflammation and drug abuse disorders. Importantly, we present the advances in engineering of ncRNAs to improve their biocompatibility and therapeutic feasibility as well as provide key insights into the applications of bioengineered non-coding RNAs that are investigated for neurological diseases.Tuhin DasTushar Kanti DasAnne KhodarkovskayaSabyasachi DashTaylor & Francis Grouparticlenon-coding rnaneurological disorderbrain functionbioengineeringnon-coding rna therapeuticsgenetic regulationbiomarkerBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021)
institution DOAJ
collection DOAJ
language EN
topic non-coding rna
neurological disorder
brain function
bioengineering
non-coding rna therapeutics
genetic regulation
biomarker
Biotechnology
TP248.13-248.65
spellingShingle non-coding rna
neurological disorder
brain function
bioengineering
non-coding rna therapeutics
genetic regulation
biomarker
Biotechnology
TP248.13-248.65
Tuhin Das
Tushar Kanti Das
Anne Khodarkovskaya
Sabyasachi Dash
Non-coding RNAs and their bioengineering applications for neurological diseases
description Engineering of cellular biomolecules is an emerging landscape presenting creative therapeutic opportunities. Recently, several strategies such as biomimetic materials, drug-releasing scaffolds, stem cells, and dynamic culture systems have been developed to improve specific biological functions, however, have been confounded with fundamental and technical roadblocks. Rapidly emerging investigations on the bioengineering prospects of mammalian ribonucleic acid (RNA) is expected to result in significant biomedical advances. More specifically, the current trend focuses on devising non-coding (nc) RNAs as therapeutic candidates for complex neurological diseases. Given the pleiotropic and regulatory role, ncRNAs such as microRNAs and long non-coding RNAs are deemed as attractive therapeutic candidates. Currently, the list of non-coding RNAs in mammals is evolving, which presents the plethora of hidden possibilities including their current scope in biomedicine. Herein, we critically review on the emerging repertoire of ncRNAs in neurological diseases such as Alzheimer’s disease, Parkinson’s disease, neuroinflammation and drug abuse disorders. Importantly, we present the advances in engineering of ncRNAs to improve their biocompatibility and therapeutic feasibility as well as provide key insights into the applications of bioengineered non-coding RNAs that are investigated for neurological diseases.
format article
author Tuhin Das
Tushar Kanti Das
Anne Khodarkovskaya
Sabyasachi Dash
author_facet Tuhin Das
Tushar Kanti Das
Anne Khodarkovskaya
Sabyasachi Dash
author_sort Tuhin Das
title Non-coding RNAs and their bioengineering applications for neurological diseases
title_short Non-coding RNAs and their bioengineering applications for neurological diseases
title_full Non-coding RNAs and their bioengineering applications for neurological diseases
title_fullStr Non-coding RNAs and their bioengineering applications for neurological diseases
title_full_unstemmed Non-coding RNAs and their bioengineering applications for neurological diseases
title_sort non-coding rnas and their bioengineering applications for neurological diseases
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/86f98868c6e049ffa0772884afa9dac1
work_keys_str_mv AT tuhindas noncodingrnasandtheirbioengineeringapplicationsforneurologicaldiseases
AT tusharkantidas noncodingrnasandtheirbioengineeringapplicationsforneurologicaldiseases
AT annekhodarkovskaya noncodingrnasandtheirbioengineeringapplicationsforneurologicaldiseases
AT sabyasachidash noncodingrnasandtheirbioengineeringapplicationsforneurologicaldiseases
_version_ 1718438954331537408